Medtronic EBITDA Margin Growth & History (MDT)
Medtronic's ebitda margin was 25.92% for fiscal 2026.
View full Medtronic company overviewMedtronic annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-24 | 25.92% | −0.37 pp |
| 2025 | 2025-04-25 | 26.29% | +2.21 pp |
| 2024 | 2024-04-26 | 24.07% | −2.13 pp |
| 2023 | 2023-04-28 | 26.20% | −0.49 pp |
| 2022 | 2022-04-29 | 26.70% | +2.84 pp |
| 2021 | 2021-04-30 | 23.86% | −1.92 pp |
| 2020 | 2020-04-24 | 25.78% | −3.43 pp |
| 2019 | 2019-04-26 | 29.21% | −1.78 pp |
| 2018 | 2018-04-27 | 31.00% | +3.06 pp |
| 2017 | 2017-04-28 | 27.94% | −0.44 pp |
| 2016 | 2016-04-29 | 28.37% | +3.34 pp |
| 2015 | 2015-04-24 | 25.03% | −2.39 pp |
| 2014 | 2014-04-25 | 27.42% | −4.05 pp |
| 2013 | 2013-04-26 | 31.47% | — |
Medtronic quarterly ebitda margin
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-07-31 | 25.55% | −0.01 pp |
| Q4 2026 | 2026-04-24 | 26.39% | +0.89 pp |
| Q3 2026 | 2026-01-31 | 25.88% | −2.21 pp |
| Q3 2026 | 2026-01-23 | 24.54% | −3.56 pp |
| Q2 2026 | 2025-10-24 | 27.13% | +0.11 pp |
| Q1 2026 | 2025-07-25 | 25.57% | +1.05 pp |
| Q4 2025 | 2025-04-25 | 25.50% | +5.62 pp |
| Q3 2025 | 2025-01-24 | 28.10% | +1.74 pp |
| Q2 2025 | 2024-10-25 | 27.01% | +1.81 pp |
| Q1 2025 | 2024-07-26 | 24.51% | −0.68 pp |
| Q4 2024 | 2024-04-26 | 19.87% | −6.38 pp |
| Q3 2024 | 2024-01-26 | 26.36% | −0.45 pp |
| Q2 2024 | 2023-10-27 | 25.20% | −2.16 pp |
| Q1 2024 | 2023-07-28 | 25.19% | +0.86 pp |
| Q4 2023 | 2023-04-28 | 26.25% | −2.91 pp |
| Q3 2023 | 2023-01-27 | 26.80% | −3.22 pp |
| Q2 2023 | 2022-10-28 | 27.36% | −1.18 pp |
| Q1 2023 | 2022-07-29 | 24.33% | +5.17 pp |
| Q4 2022 | 2022-04-29 | 29.16% | +1.22 pp |
| Q3 2022 | 2022-01-28 | 30.03% | +4.88 pp |
| Q2 2022 | 2021-10-29 | 28.53% | +7.60 pp |
| Q1 2022 | 2021-07-30 | 19.16% | −1.47 pp |
| Q4 2021 | 2021-04-30 | 27.94% | +11.47 pp |
| Q3 2021 | 2021-01-29 | 25.14% | −4.69 pp |
| Q2 2021 | 2020-10-30 | 20.94% | −5.30 pp |
| Q1 2021 | 2020-07-31 | 20.62% | −7.96 pp |
| Q4 2020 | 2020-04-24 | 16.47% | −15.60 pp |
| Q3 2020 | 2020-01-24 | 29.83% | +0.45 pp |
| Q2 2020 | 2019-10-25 | 26.24% | −3.10 pp |
| Q1 2020 | 2019-07-26 | 28.59% | +2.83 pp |
| Q4 2019 | 2019-04-26 | 32.08% | +0.25 pp |
| Q3 2019 | 2019-01-25 | 29.38% | +0.85 pp |
| Q2 2019 | 2018-10-26 | 29.34% | −7.14 pp |
| Q1 2019 | 2018-07-27 | 25.76% | −1.55 pp |
| Q4 2018 | 2018-04-27 | 31.83% | +1.48 pp |
| Q3 2018 | 2018-01-26 | 28.52% | +2.75 pp |
| Q2 2018 | 2017-10-27 | 36.48% | +7.66 pp |
| Q1 2018 | 2017-07-28 | 27.31% | +0.74 pp |
| Q4 2017 | 2017-04-28 | 30.34% | +0.17 pp |
| Q3 2017 | 2017-01-27 | 25.77% | −4.08 pp |
| Q2 2017 | 2016-10-28 | 28.82% | +0.54 pp |
| Q1 2017 | 2016-07-29 | 26.57% | +1.38 pp |
| Q4 2016 | 2016-04-29 | 30.17% | +15.79 pp |
| Q3 2016 | 2016-01-29 | 29.85% | −4.45 pp |
| Q2 2016 | 2015-10-30 | 28.28% | −0.08 pp |
| Q1 2016 | 2015-07-31 | 25.19% | −5.31 pp |
| Q4 2015 | 2015-04-24 | 14.38% | — |
| Q3 2015 | 2015-01-23 | 34.30% | — |
| Q2 2015 | 2014-10-24 | 28.36% | — |
| Q1 2015 | 2014-07-25 | 30.49% | — |
Medtronic ebitda margin trends
Over the last five fiscal years, Medtronic's ebitda margin increased from 23.86% to 25.92%, a change of +2.06 percentage points. The latest reported quarter, Q1 2027, shows 25.55%.
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...